Safety of Annona muricata Extract Supplementation for Colorectal Cancer Patients

Authors

  • Lili Indrawati Department of Pharmacotherapy, Faculty of Medicine, Universitas Kristen Indonesia, Jakarta
  • Purwantyastuti Purwantyastuti Department of Pharmacology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
  • Murdani Abdullah Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mnagunkusumo General National Hospital, Jakarta
  • Ingrid S Surono Food Technology Department, Faculty of Engineering, Bina Nusantara University, Jakarta
  • Ibrahim Basir Department of Surgery, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta

DOI:

https://doi.org/10.24871/1732016170-175

Keywords:

colorectal cancer, Annona muricata leaves, adverse effect, vital organs

Abstract

Background: People have used Annona muricata leaves traditionally as tea drinks. Traditional use of A. muricata leaves is as an infusion which is closed to water extract. The potential health benefit of A. muricata tea leaves that is traditionally used for maintaining health which lately is being used by cancer patients. Therefore it is urgent to verify the safety of A. muricata leaves extract. 

Method: A randomized double blind placebo controlled trial was conducted on 30 colorectal cancer out patients who had undergone primary tumor resection. Twenty eight subjects completed the study, divided into two groups, namely ethanol-soluble fraction of A. muricata leaves water extract (ESFAM) (n = 14), and placebo (n = 14) for 8 weeks. Peripheral blood samples were withdrawn from subjects by venipuncture at baseline and at the end of the study period.

Results: The effect on bone marrow can be considered to be safe.  The measure in indices of organs function, i.e liver and kidney also showed similar results and within normal range after supplementation. The dose given to the subjects is safe and highly tolerable, as shown by very few (6.7%) of patients complained intolerable adverse effects.  

Conclusion: This study indicates the safety of  ESFAM  supplementation.

 

Downloads

Published

2017-03-14

How to Cite

Indrawati, L., Purwantyastuti, P., Abdullah, M., Surono, I. S., & Basir, I. (2017). Safety of Annona muricata Extract Supplementation for Colorectal Cancer Patients. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 17(3), 170–175. https://doi.org/10.24871/1732016170-175

Issue

Vol. 17 No. 3 (2016): VOLUME 17, NUMBER 3, December 2016

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).